1. Home
  2. CVAC vs THRM Comparison

CVAC vs THRM Comparison

Compare CVAC & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • THRM
  • Stock Information
  • Founded
  • CVAC 2000
  • THRM 1991
  • Country
  • CVAC Germany
  • THRM United States
  • Employees
  • CVAC N/A
  • THRM N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • THRM Auto Parts:O.E.M.
  • Sector
  • CVAC Health Care
  • THRM Consumer Discretionary
  • Exchange
  • CVAC Nasdaq
  • THRM Nasdaq
  • Market Cap
  • CVAC 1.2B
  • THRM 997.7M
  • IPO Year
  • CVAC 2020
  • THRM 1993
  • Fundamental
  • Price
  • CVAC $5.48
  • THRM $35.48
  • Analyst Decision
  • CVAC Hold
  • THRM Buy
  • Analyst Count
  • CVAC 3
  • THRM 3
  • Target Price
  • CVAC $6.83
  • THRM $46.00
  • AVG Volume (30 Days)
  • CVAC 789.9K
  • THRM 306.1K
  • Earning Date
  • CVAC 08-18-2025
  • THRM 07-24-2025
  • Dividend Yield
  • CVAC N/A
  • THRM N/A
  • EPS Growth
  • CVAC N/A
  • THRM N/A
  • EPS
  • CVAC 0.87
  • THRM 1.02
  • Revenue
  • CVAC $566,039,775.00
  • THRM $1,453,370,000.00
  • Revenue This Year
  • CVAC N/A
  • THRM $1.09
  • Revenue Next Year
  • CVAC $24.04
  • THRM $3.26
  • P/E Ratio
  • CVAC $6.35
  • THRM $34.87
  • Revenue Growth
  • CVAC 787.60
  • THRM N/A
  • 52 Week Low
  • CVAC $2.37
  • THRM $22.75
  • 52 Week High
  • CVAC $5.72
  • THRM $52.06
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 60.60
  • THRM 66.75
  • Support Level
  • CVAC $5.41
  • THRM $32.22
  • Resistance Level
  • CVAC $5.54
  • THRM $36.17
  • Average True Range (ATR)
  • CVAC 0.05
  • THRM 1.17
  • MACD
  • CVAC -0.01
  • THRM 0.14
  • Stochastic Oscillator
  • CVAC 73.68
  • THRM 85.04

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Share on Social Networks: